Roche
ROG.SW
#36
Rank
NZ$556.63 B
Marketcap
NZ$693.84
Share price
0.50%
Change (1 day)
43.14%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2023: NZ$29.62

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$29.62. In 2023 the company made an earnings per share (EPS) of NZ$29.62 an increase over its 2022 EPS that were of NZ$29.05.

EPS history for Roche from 1998 to 2023

Annual EPS

Year EPS Change
2023NZ$29.621.95%
2022NZ$29.05-6.29%
2021NZ$31.00-5.53%
2020NZ$32.8216.56%
2019NZ$28.1530.3%
2018NZ$21.6120.22%
2017NZ$17.97-5.81%
2016NZ$19.084.62%
2015NZ$18.24-5.13%
2014NZ$19.22-25.05%
2013NZ$25.6521.73%
2012NZ$21.073.82%
2011NZ$20.298.16%
2010NZ$18.7623.72%
2009NZ$15.17-12.31%
2008NZ$17.29-0.34%
2007NZ$17.3532.13%
2006NZ$13.1342.56%
2005NZ$9.21-22.7%
2004NZ$11.92132.85%
2003NZ$5.12-148.96%
2002NZ-$10.45-209.09%
2001NZ$9.58-57.25%
2000NZ$22.4154.06%
1999NZ$14.5531.24%
1998NZ$11.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.05-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.13-55.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.97-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.41-78.36%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$12.73-57.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$6.22-79.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$13.93-52.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.53-23.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.63-67.48%๐Ÿ‡บ๐Ÿ‡ธ USA